These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15011408)

  • 41. Myoclonus in parkinsonian disorders.
    Shafiq M; Lang AE
    Adv Neurol; 2002; 89():77-83. PubMed ID: 11968474
    [No Abstract]   [Full Text] [Related]  

  • 42. Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database.
    Szarfman A; Doraiswamy PM; Tonning JM; Levine JG
    Arch Neurol; 2006 Feb; 63(2):299-300; author reply 300. PubMed ID: 16476828
    [No Abstract]   [Full Text] [Related]  

  • 43. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    Mov Disord; 1998 Sep; 13(5):798-802. PubMed ID: 9756148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Useful data on parkinsonian syndromes].
    Espadaler Medina JM
    Med Clin (Barc); 1985 May; 84(20):828-33. PubMed ID: 4033265
    [No Abstract]   [Full Text] [Related]  

  • 45. Off-period screaming accompanying motor fluctuations in Parkinson's disease.
    Steiger MJ; Quinn NP; Toone B; Marsden CD
    Mov Disord; 1991; 6(1):89-90. PubMed ID: 2005932
    [No Abstract]   [Full Text] [Related]  

  • 46. New use for an old drug: amantadine benefits levodopa-induced dyskinesia.
    Rajput AH; Rajput A; Lang AE; Kumar R; Uitti RJ; Galvez-Jimenez N
    Mov Disord; 1998 Sep; 13(5):851. PubMed ID: 9756161
    [No Abstract]   [Full Text] [Related]  

  • 47. Levodopa-induced dyskinesias in spinocerebellar ataxia type 2.
    Ferrara JM; Adam OR; Ondo WG
    Arch Neurol; 2010 Jan; 67(1):114-5. PubMed ID: 20065139
    [No Abstract]   [Full Text] [Related]  

  • 48. [Dopaminomimetic psychosis in Parkinson's disease: first symptom of early dementia?].
    Catalan-Alonso MJ; Del Val J
    Rev Neurol; 2001 Jun 1-15; 32(11):1085-7. PubMed ID: 11562835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
    Hely MA; Morris JG; Reid WG; Trafficante R
    Mov Disord; 2005 Feb; 20(2):190-9. PubMed ID: 15551331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of levodopa effects by internal pallidal stimulation.
    Krack P; Pollak P; Limousin P; Hoffmann D; Benazzouz A; Benabid AL
    Mov Disord; 1998 Jul; 13(4):648-52. PubMed ID: 9686769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Drug-induced dementia].
    Kojima T; Akishita M
    Nihon Rinsho; 2016 Mar; 74(3):510-4. PubMed ID: 27025096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis and management of atypical parkinsonian syndromes.
    Brooks DJ
    J Neurol Neurosurg Psychiatry; 2002 Mar; 72 Suppl 1(Suppl 1):I10-I16. PubMed ID: 11870198
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiparkinsonian drugs and visual hallucinations.
    Rossi S; Bartalini S; Ulivelli M
    Lancet Neurol; 2006 Jan; 5(1):18-9; author reply 19-20. PubMed ID: 16361017
    [No Abstract]   [Full Text] [Related]  

  • 54. Anticholinergic drugs and dementia in older adults.
    Gray SL; Hanlon JT
    BMJ; 2018 Apr; 361():k1722. PubMed ID: 29695471
    [No Abstract]   [Full Text] [Related]  

  • 55. Anticholinergic Drug Use Associated with Risk of Dementia.
    Pfeifer GM; Zolot J
    Am J Nurs; 2019 Oct; 119(10):13. PubMed ID: 31567233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primum non nocere: Anticholinergics and dementia.
    Elston DM
    J Am Acad Dermatol; 2018 Sep; 79(3):439-440. PubMed ID: 30119867
    [No Abstract]   [Full Text] [Related]  

  • 57. [Not Available].
    Grosjean A; Fumeaux T
    Rev Med Suisse; 2019 Sep; 15(664):1728. PubMed ID: 31553541
    [No Abstract]   [Full Text] [Related]  

  • 58. Response to Lertxundi and colleagues.
    Kalisch Ellett LM; Pratt NL; Ramsay EN; Barratt JD; Roughead EE
    J Am Geriatr Soc; 2015 May; 63(5):1054-5. PubMed ID: 25989587
    [No Abstract]   [Full Text] [Related]  

  • 59. Confusion regarding anticholinergic burden measurement.
    Lertxundi U; Domingo-Echaburu S; Hernández R; Peral-Aguirregoitia J; Medrano J
    J Am Geriatr Soc; 2015 May; 63(5):1054. PubMed ID: 25989588
    [No Abstract]   [Full Text] [Related]  

  • 60. Re: Long-Term Cognitive and Functional Effects of Potentially Inappropriate Medications in Older Women.
    Griebling TL
    J Urol; 2016 Feb; 195(2):422-3. PubMed ID: 26852995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.